Skip to main content

#156378

Anti-ALT-2

Cat. #156378

Anti-ALT-2

Cat. #: 156378

Unit size: 100 ug

Availability: 10-12 weeks

Target: Abundant Larval Transcript-2

Class: Polyclonal

Application: WB ; FACS ; ELISA

Host: Jird

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: University of Illinois Chicago

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-ALT-2
  • Alternate name: ALT
  • Research fields: Immunology;Microbiology
  • Class: Polyclonal
  • Conjugation: Unconjugated
  • Host: Jird
  • Application: WB ; FACS ; ELISA
  • Description: Lymphatic filariasis, caused by Brugia malayi and others, affects more than 120 million people worldwide causing major public health problems especially in the tropics. Brugia malayi - ALT-2 protein is abundantly synthesized in the infective stages of the parasite and believed to play a major role in the transmission and infectivity of the filarial parasite. Bm-alt-2 has several important characteristics of a vaccine candidate. These include high levels of expression in the infective larval stages presenting as an abundant target for the immune system and more importantly there is no known homolog in the mammalian species.
  • Immunogen: Recombinant Bm-ALT-2 protein

Target Details

  • Target: Abundant Larval Transcript-2
  • Target background: Lymphatic filariasis, caused by Brugia malayi and others, affects more than 120 million people worldwide causing major public health problems especially in the tropics. Brugia malayi - ALT-2 protein is abundantly synthesized in the infective stages of the parasite and believed to play a major role in the transmission and infectivity of the filarial parasite. Bm-alt-2 has several important characteristics of a vaccine candidate. These include high levels of expression in the infective larval stages presenting as an abundant target for the immune system and more importantly there is no known homolog in the mammalian species.

Applications

  • Application: WB ; FACS ; ELISA

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Dry ice

References

  • Thirugnanam et al. 2007. Exp Parasitol. 116(4):483-91. PMID: 17442307.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.